Back

Association of Life’s Essential 8 and its components with adverse cardiovascular and kidney events in patients with atherosclerotic cardiovascular disease: a prospective cohort study

31 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Lipid risk factors and prevention of cardiovascular disease Cardiovascular Risk Assessment ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Ziyao Yuan

(China)

6 More presentations in this session

Presentation thumbnail
A blood‑derived 5‑microRNA signature of atherosclerotic cardiovascular disease resilience in genetically confirmed familial hypercholesterolemia
Doctor T. Padro (Barcelona, ES)
Abstract
Presentation thumbnail
Clinical utility of the modified controlling nutritional status score for predicting atherosclerotic severity and prognosis in statin-treated patients with atherosclerotic cardiovascular disease
Doctor N. Kuroki (JP)
Abstract
Presentation thumbnail
Apolipoprotein B beyond LDL-cholesterol in predicting Atherosclerotic Cardiovascular Disease risk in high-risk populations
Ms S. Demeester (US)
Abstract
Presentation thumbnail
Beyond the stent: routine vascular ultrasound after PCI reveals polyvascular extreme risk without intensified LDL‑cholesterol lowering therapy
Doctor K. Mahajan (Mandi, IN)
Abstract
Presentation thumbnail
Risk of all-cause mortality and transcontinental differences in angiopoietin-like 4 protein and lipids in patients admitted with chest pain of suspected coronary origin.
Doctor R. LEON DE LA FUENTE (Salta, AR)
Abstract

Access the full session

Session thumbnail
Lipid risk factors and prevention of cardiovascular disease

The Event

Event poster

ESC Congress 2026

31 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
LE8 score in relation to cardiovascular disease and mortality in individuals with diabetes
1 September 2024
thumbnail
Congress Presentation
Visit-to-visit glomerular filtration rate variability as a predictor for cardiovascular and renal outcomes in essential hypertension: Data from a Greek 8-year-follow-up study
3 September 2019
thumbnail
Congress Presentation
Residual atherosclerotic risk in older patients with ASCVD: where hsCRP meets Lp(a)
30 August 2025
thumbnail
Congress Presentation
Prevalence, determinants, and time trends of LS7 Cardiovascular Health in the WHO African Region 2003 to 2022
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources